Neurology® Podcast

Prof. Jon Stone talks with Dr. Laura Strom and Meagan Watson about changes in total emergency department and inpatient visits and costs before and after referral to a specialized, comprehensive functional seizure treatment clinic. Read the related article with Neurology® Clinical Practice. Disclosures can be found at Neurology.org.

Neurology® Open Access has officially launched. In this episode, Dr. Jeff Ratliff and NOA Editor, Dr. Amy C. Kunchok share insights about Neurology® Open Access (NOA). Read more about Neurology® Open Access in this editorial, and visit the Neurology® Open Access website. Disclosures can be found at Neurology.org.

Dr. Jeff Ratliff talks with Dr. Mehari Gebreyohanns, the recipient of the 2025 Ted Burns Humanism in Neurology Award, about his journey into stroke care, the BORNE initiative, and the challenges faced in global neurology. Disclosures can be found at Neurology.org.

The April 2025 replay showcases five compelling physician-as-patient stories. The episode begins with Dr. Franzi Herpich sharing her personal experience of suffering a stroke. It then transitions into a two-part series on arteriovenous malformation, featuring stories from Dr. Joe Sirven and Dr. Amy Hessler. The fourth episode highlights Dr. Eric Seachrist's journey with multiple sclerosis. In the final episode, Dr. Andrea Lendaris discusses her experience with Usher syndrome type 2A and her ongoing battle with acute and chronic health challenges. Podcast links: Physician as Patient - Stroke Physicians as Patients Series - Arteriovenous Malformation - Part 1 Physicians as Patients Series - Arteriovenous Malformation - Part 2 Physician as Patient Series - Multiple Sclerosis Physicians as Patients Series - Inclusivity of Physicians with Disabilities April 2022 Recall: Physician as Patient Disclosures can be found at Neurology.org.

Dr. Jennifer Morganroth, a Neuromuscular and EMG fellow at Columbia, discusses the dramatic increase in thymectomy procedures for myasthenia gravis since the groundbreaking MGTX trial in 2016. She highlights significant disparities in access to these surgeries, especially among African-American patients and women. The conversation also delves into the impact of hospital characteristics and patient communication on treatment availability. Moreover, they explore the shift towards minimally invasive surgical techniques and the implications of new non-surgical treatments for future practices.

Dr. Stefan Pulst, Chair of Neurology and Human Genetics at the University of Utah, delves into a decade of transformative changes in neurology genetics. He discusses the impact of the dedicated journal launched in 2015, which has helped connect genetic variants to rare diseases. The conversation highlights significant advances in genetic testing and how these developments are shaping personalized treatments. Lastly, he touches on the challenges of developing genetic therapies and the importance of collaboration and mentorship within the growing neurogenetics community.

Francesca Puledda, a neurologist from King's College London and author of the International Headache Society's guidelines, shares valuable insights on migraine management. She highlights the importance of tailoring treatment to individual patient needs and regional medication availability. The discussion covers acute treatments like triptans, unique considerations for pregnant women, and the complexities of preventive therapies. Puledda emphasizes a patient-centric approach that balances diverse options with satisfaction, ensuring comprehensive care for migraine sufferers.

Dr. Phillip Ferdinand, a stroke physician at Royal Stoke University Hospital and Keele University, shares insights on the alarming association between smoking and cryptogenic ischemic strokes in young adults. He discusses how smoking intensity correlates with stroke incidence, particularly in males aged 18 to 49. The conversation touches on rising trends in stroke incidents among younger populations and highlights the importance of evaluating social determinants of health. Ferdinand emphasizes the need for tailored prevention strategies and further research into smoking's impact on stroke outcomes.

Timothy Miller, an esteemed neurologist and ALS expert from Washington University, discusses groundbreaking advancements in ALS treatment using Tofersen. He highlights remarkable patient stories, including a patient who experienced a significant recovery after transitioning to the therapy. Miller emphasizes the importance of early intervention, revealing compelling clinical data that showcases promising slowdowns in disease progression. With a focus on shared mechanisms and ongoing research, he fuels optimism for future therapies that could transform ALS into a more treatable condition.

Dr. Amy Brodtmann, director at the Eastern Cognitive Disorders Clinic and professor, joins to discuss the nuances of diagnosing frontotemporal dementia (FTD). She emphasizes the holistic approach needed in assessments, particularly regarding behavioral changes that may mask underlying conditions. The conversation delves into the complexities of distinguishing FTD from Alzheimer's disease and the potential for misdiagnosis. Brodtmann highlights the critical role of follow-up care and emerging blood biomarkers to enhance diagnostic accuracy, shedding light on an often-overlooked area in dementia care.